Share Price:

APNASPENAspen Pharmacare Hldgs159380 (0.00%)

Aspen is in a closed period from 1st July 2026 until the publication of the annual results on the JSE SENS platform on the 2nd September 2026.

From innovation to immunisation: Aspen adds Africa’s voice to global vaccine dialogue in Beijing

Screenshot

Aspen contributed an important African perspective to the 27th Annual General Meeting of the Developing Countries Vaccine Manufacturers Network (DCVMN), which took place in Beijing, China, from 22 to 24 September 2026. Representing Aspen and the Southern African region, our Group Senior Executive: Strategic Trade, Stavros Nicolaou participated in his capacity as an elected member of the DCVMN Board of Directors.

Closed Period

Aspen is in a closed period from 1st January 2026 until the publication of the interim results on the JSE SENS platform on the 3rd March 2026.

The live presentation will take place in Cape Town at 08h30 on 2 March 2023.

Corporate

Our career opportunities are across the corporate spectrum, including Human Capital, Digital Technology, Legal, and Risk & Sustainability. Our employees are given the opportunity to hone their skills and develop the experience of excellence in their chosen field in the pharmaceutical industry.

View our teams below: